E A Strating

Cancer Center Amsterdam

Papers

1

Total Citations

55

H-Index

1

About

Dr. E. A. Strating is a leading clinical researcher in surgical oncology, with a primary focus on pancreatic surgery and the comparative effectiveness of minimally invasive versus open procedures. Their most impactful work stems from the landmark LEOPARD trial, a randomized study that established minimally invasive distal pancreatectomy as superior to open surgery in reducing time to functional recovery. Dr. Strating’s contributions extend beyond clinical outcomes to include rigorous health economic and quality-of-life analyses, demonstrating that the minimally invasive approach is both cost-effective and improves disease-specific quality of life. This work, cited over 55 times, has directly influenced surgical guidelines and practice patterns worldwide. By integrating patient-reported outcomes with cost data, Dr. Strating has provided a comprehensive evidence base that helps surgeons and hospitals make informed decisions about adopting new techniques. Their research exemplifies how high-quality randomized trials can transform surgical care, balancing innovation with practical considerations of value and patient well-being.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial)
55 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Cancer Center Amsterdam

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago